Skip to main content
Fig. 4 | Alzheimer's Research & Therapy

Fig. 4

From: Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice

Fig. 4

AV-1959R/A and AV-1980R/A immune sera (both separately and mixture), but not AdvaxCpG injected (control) sera bound to the 50-μm brain sections of cortical tissues from an AD case, female 89 years old, Plaque stage-C, Tangle stage-6. Brain sections were stained with anti-Aβ (beta-amyloid (1–42), 1:250) and humanized anti-tau (Armanezumab, 1:1000) antibody as positive controls (scale = 20 μm)

Back to article page